Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 3Stomach Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Colorectal Neoplasms 2Thyroid Nodule 1Recurrence 1Locally Advanced Pancreatic Cancer 1Liver Cirrhosis 1Inflammatory Bowel Diseases 1Hypertension, Portal 1Gastrointestinal Neoplasms 1Fibrosis 1Esophageal Neoplasms 1Colonic Neoplasms 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Ultrasonography 2Tomography, X-Ray Computed 2Colonoscopy 2Blood Specimen Collection 2tremelimumab 1peginterferon alfa-2a 1lenvatinib 1hepatitis C immune globulin, human 1fluoromisonidazole 1epigallocatechin gallate 1durvalumab 1babao dan 1Weights and Measures 1Vitamin B 6 1Urination 1Tomography 1Tidal Volume 1Tenofovir 1Surgical Procedures, Operative 1Standard of Care 1Shadowing Technique, Histology 1Radiomics 1Propranolol 1Probiotics 1Preoperative Exercise 1Positron-Emission Tomography 1Portasystemic Shunt, Transjugular Intrahepatic 1Population Groups 1Plasmapheresis 1Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Cirrhosis × Diagnostic Imaging × Gastrointestinal × Clear all
NCT06265272 2025-09-26

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

Massachusetts General Hospital

Recruiting
45 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hypertension, Portal, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡